nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B1—adrenal cortex—bipolar disorder	0.0746	0.241	CbGeAlD
Trilostane—HSD3B1—Glucocorticoid biosynthesis—POMC—bipolar disorder	0.0603	0.0875	CbGpPWpGaD
Trilostane—HSD3B2—adrenal cortex—bipolar disorder	0.0591	0.191	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—ADRBK2—bipolar disorder	0.0501	0.0728	CbGpPWpGaD
Trilostane—HSD3B1—Androgen biosynthesis—POMC—bipolar disorder	0.0467	0.0678	CbGpPWpGaD
Trilostane—HSD3B2—Glucocorticoid biosynthesis—POMC—bipolar disorder	0.0457	0.0663	CbGpPWpGaD
Trilostane—HSD3B1—cerebellum—bipolar disorder	0.0411	0.133	CbGeAlD
Trilostane—HSD3B2—Corticotropin-releasing hormone—ADRBK2—bipolar disorder	0.038	0.0551	CbGpPWpGaD
Trilostane—HSD3B2—Androgen biosynthesis—POMC—bipolar disorder	0.0354	0.0514	CbGpPWpGaD
Trilostane—HSD3B2—nervous system—bipolar disorder	0.0346	0.112	CbGeAlD
Trilostane—HSD3B2—brain—bipolar disorder	0.0265	0.0854	CbGeAlD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—POMC—bipolar disorder	0.0194	0.0282	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—NR1D1—bipolar disorder	0.0182	0.0264	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—POMC—bipolar disorder	0.0147	0.0214	CbGpPWpGaD
Trilostane—ESR2—thyroid gland—bipolar disorder	0.0134	0.0433	CbGeAlD
Trilostane—ESR2—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.0133	0.0193	CbGpPWpGaD
Trilostane—ESR2—nervous system—bipolar disorder	0.0113	0.0364	CbGeAlD
Trilostane—ESR2—cerebellum—bipolar disorder	0.0106	0.0343	CbGeAlD
Trilostane—ESR1—thyroid gland—bipolar disorder	0.0092	0.0297	CbGeAlD
Trilostane—ESR1—Nuclear Receptor transcription pathway—NR1D1—bipolar disorder	0.00918	0.0133	CbGpPWpGaD
Trilostane—ESR2—brain—bipolar disorder	0.00864	0.0279	CbGeAlD
Trilostane—HSD3B1—Corticotropin-releasing hormone—GSK3B—bipolar disorder	0.00862	0.0125	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00857	0.0124	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—POMC—bipolar disorder	0.00855	0.0124	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—NR3C1—bipolar disorder	0.0078	0.0113	CbGpPWpGaD
Trilostane—ESR1—nervous system—bipolar disorder	0.00774	0.025	CbGeAlD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00769	0.0112	CbGpPWpGaD
Trilostane—ESR1—cerebellum—bipolar disorder	0.00728	0.0235	CbGeAlD
Trilostane—HSD3B1—Metabolism—IMPA2—bipolar disorder	0.00686	0.00995	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—GSK3B—bipolar disorder	0.00653	0.00948	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00649	0.00942	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—POMC—bipolar disorder	0.00648	0.0094	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—SERPINA1—bipolar disorder	0.00641	0.00931	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—NR3C1—bipolar disorder	0.00616	0.00895	CbGpPWpGaD
Trilostane—ESR1—brain—bipolar disorder	0.00592	0.0191	CbGeAlD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00583	0.00846	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—GSK3A—bipolar disorder	0.00546	0.00792	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.0054	0.00783	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00521	0.00757	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—IMPA1—bipolar disorder	0.00521	0.00756	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—IMPA2—bipolar disorder	0.0052	0.00754	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.00492	0.00713	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.00492	0.00713	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—IMPA1—bipolar disorder	0.00463	0.00672	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—S100B—bipolar disorder	0.00463	0.00672	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00453	0.00657	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—NRG1—bipolar disorder	0.00409	0.00593	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00407	0.00591	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00401	0.00582	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00395	0.00573	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NDUFV2—bipolar disorder	0.00394	0.00572	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—NR3C1—bipolar disorder	0.00393	0.00571	CbGpPWpGaD
Trilostane—ESR1—Signaling events mediated by HDAC Class II—NR3C1—bipolar disorder	0.00393	0.00571	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00393	0.0057	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00393	0.0057	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00393	0.0057	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.00382	0.00555	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C4—bipolar disorder	0.00381	0.00554	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—IMPA1—bipolar disorder	0.00351	0.0051	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—GSK3A—bipolar disorder	0.00343	0.00498	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00343	0.00498	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NR1D1—bipolar disorder	0.00343	0.00497	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—GATA3—bipolar disorder	0.00335	0.00486	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TCF7L2—bipolar disorder	0.00332	0.00482	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NCAN—bipolar disorder	0.00328	0.00476	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00322	0.00468	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC5A3—bipolar disorder	0.00321	0.00466	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR1D1—bipolar disorder	0.00315	0.00457	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—NR3C1—bipolar disorder	0.00311	0.00451	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDUFV2—bipolar disorder	0.00299	0.00433	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00296	0.00429	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C4—bipolar disorder	0.00289	0.0042	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00285	0.00414	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—GSK3B—bipolar disorder	0.00274	0.00398	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—INS—bipolar disorder	0.00266	0.00386	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.00265	0.00385	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NR1D1—bipolar disorder	0.0026	0.00377	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00252	0.00366	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NCAN—bipolar disorder	0.00248	0.00361	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC5A3—bipolar disorder	0.00243	0.00353	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.00243	0.00352	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—NR3C1—bipolar disorder	0.00241	0.0035	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00241	0.0035	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CLOCK—bipolar disorder	0.00232	0.00337	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TPH2—bipolar disorder	0.00226	0.00328	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TSHB—bipolar disorder	0.00226	0.00328	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CACNB2—bipolar disorder	0.00226	0.00328	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—DPYD—bipolar disorder	0.00223	0.00323	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—bipolar disorder	0.00215	0.00312	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—INS—bipolar disorder	0.0021	0.00305	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CACNA1C—bipolar disorder	0.00207	0.003	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3C2A—bipolar disorder	0.00202	0.00293	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.00199	0.00289	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—GSK3A—bipolar disorder	0.00196	0.00285	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GSK3A—bipolar disorder	0.00195	0.00283	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SNAP25—bipolar disorder	0.00181	0.00263	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CLOCK—bipolar disorder	0.00176	0.00255	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—GSK3B—bipolar disorder	0.00176	0.00255	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TSHB—bipolar disorder	0.00171	0.00249	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPH2—bipolar disorder	0.00171	0.00249	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CACNB2—bipolar disorder	0.00171	0.00249	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—DPYD—bipolar disorder	0.00169	0.00245	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00162	0.00236	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ADCY2—bipolar disorder	0.0016	0.00232	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR1D1—bipolar disorder	0.00159	0.0023	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CACNA1C—bipolar disorder	0.00157	0.00228	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—S100B—bipolar disorder	0.00156	0.00226	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3C2A—bipolar disorder	0.00153	0.00222	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR1D1—bipolar disorder	0.00151	0.0022	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.00151	0.00219	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00143	0.00207	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRG1—bipolar disorder	0.00138	0.002	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—COMT—bipolar disorder	0.00137	0.00199	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SNAP25—bipolar disorder	0.00137	0.00199	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MAOA—bipolar disorder	0.00136	0.00198	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.00134	0.00194	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—bipolar disorder	0.00129	0.00188	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.00122	0.00178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ADCY2—bipolar disorder	0.00121	0.00176	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—bipolar disorder	0.00111	0.00161	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR3C1—bipolar disorder	0.00106	0.00155	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—COMT—bipolar disorder	0.00104	0.00151	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MAOA—bipolar disorder	0.00103	0.0015	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GSK3B—bipolar disorder	0.000999	0.00145	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—POMC—bipolar disorder	0.000886	0.00129	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INS—bipolar disorder	0.000881	0.00128	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—bipolar disorder	0.00084	0.00122	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR1D1—bipolar disorder	0.000764	0.00111	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—POMC—bipolar disorder	0.000671	0.000975	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INS—bipolar disorder	0.000668	0.000969	CbGpPWpGaD
Trilostane—Testosterone—MAOA—bipolar disorder	0.000555	0.585	CrCbGaD
Trilostane—ESR1—Signaling Pathways—AKR1C4—bipolar disorder	0.000553	0.000802	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR3C1—bipolar disorder	0.000537	0.000779	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR3C1—bipolar disorder	0.000513	0.000744	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DGKH—bipolar disorder	0.000509	0.000738	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD5—bipolar disorder	0.000465	0.000675	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RGS4—bipolar disorder	0.000456	0.000662	CbGpPWpGaD
Trilostane—Progesterone—NR3C1—bipolar disorder	0.000394	0.415	CrCbGaD
Trilostane—ESR1—Signaling Pathways—TRPC3—bipolar disorder	0.000353	0.000512	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADM—bipolar disorder	0.000336	0.000488	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PDE4B—bipolar disorder	0.000328	0.000476	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TSHB—bipolar disorder	0.000328	0.000476	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TACR1—bipolar disorder	0.000328	0.000476	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR1A—bipolar disorder	0.000271	0.000394	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TAC1—bipolar disorder	0.000267	0.000388	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2C—bipolar disorder	0.000262	0.00038	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD1—bipolar disorder	0.000262	0.00038	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR3C1—bipolar disorder	0.000258	0.000375	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK2—bipolar disorder	0.000255	0.00037	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD3—bipolar disorder	0.000254	0.000368	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GSK3A—bipolar disorder	0.000253	0.000367	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD4—bipolar disorder	0.000246	0.000358	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADCY2—bipolar disorder	0.000232	0.000337	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TCF7L2—bipolar disorder	0.000231	0.000335	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD2—bipolar disorder	0.00023	0.000333	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK1—bipolar disorder	0.000208	0.000302	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—S100B—bipolar disorder	0.000202	0.000293	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRG1—bipolar disorder	0.000178	0.000259	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2A—bipolar disorder	0.000161	0.000233	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GSK3B—bipolar disorder	0.000129	0.000188	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—POMC—bipolar disorder	0.000128	0.000186	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INS—bipolar disorder	0.000128	0.000185	CbGpPWpGaD
